44
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Opsonising Immunoglobulins and Mannan-Binding Lectin in Chronic Lymphocytic Leukemia

, , , , , & show all
Pages 381-385 | Received 30 Oct 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michael Asger Andersen, Fie Juhl Vojdeman, Mette Klarskov Andersen, Peter de Nully Brown, Christian Hartmann Geisler, Ole Weis Bjerrum & Carsten Utoft Niemann. (2016) Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death. Leukemia & Lymphoma 57:7, pages 1592-1599.
Read now
Marjatta Sinisalo, Janne Aittoniemi, Tomi Koski, Gerard Tobin, Ulf Thunberg, Christer Sundström, Richard Rosenquist, Helena Käyhty & Juhani Vilpo. (2004) Similar Humoral Immunity Parameters in Chronic Lymphocytic Leukemia Patients Independent of VH Gene Mutation Status. Leukemia & Lymphoma 45:12, pages 2451-2454.
Read now
Marjatta Sinisalo, Janne Aittoniemi, Helena Käyhty & Juhani Vilpo. (2002) Haemophilus Influenzae Type b (Hib) Antibody Concentrations and Vaccination Responses in Patients with Chronic Lymphocytic Leukaemia: Predicting Factors for Response. Leukemia & Lymphoma 43:10, pages 1967-1969.
Read now
Vicki A Morrison. (2001) Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 1:1, pages 84-90.
Read now

Articles from other publishers (21)

Serhat Çelik, Leylagül Kaynar, Zeynep Tuğba Güven, Mustafa Baydar, Muzaffer Keklik, Mustafa Çetin, Ali Ünal & Fatih Demirkan. (2021) Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. Indian Journal of Hematology and Blood Transfusion 38:2, pages 282-289.
Crossref
Alessandro Allegra, Alessandro Tonacci, Caterina Musolino, Giovanni Pioggia & Sebastiano Gangemi. (2021) Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Frontiers in Immunology 12.
Crossref
Matthew Stankowicz, Megan Banaszynski & Russell Crawford. (2018) Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia. Journal of Oncology Pharmacy Practice 25:3, pages 710-714.
Crossref
Erden ATİLLA, Fulya ÖZEL, Pınar ATACA ATİLLA, Pervin TOPÇUOĞLU, Hamdi AKAN, Meral BEKSAÇ, Osman İLHAN, Muhit ÖZCAN, Önder ARSLAN, Günhan GÜRMAN & Selami Koçak TOPRAK. (2018) KRONİK LENFOSİTİK LÖSEMİ’DE TANI ANINDA HİPOGAMMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYON RİSKİ ÜZERİNDE ETKİLİ MİDİR?Is Hypogammaglobulinemia Present at Diagnosis of Chronic Lymphocytic Leukemia effective on Survival and Risks of Infection?. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 20:3, pages 294-299.
Crossref
Silvia Sánchez-Ramón, Fatima Dhalla & Helen Chapel. (2016) Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. Frontiers in Immunology 7.
Crossref
Dariusz Wołowiec. (2013) Powikłania infekcyjne i autoimmunologiczne w przewlekłej białaczce limfocytowej. Acta Haematologica Polonica 44:3, pages 188-195.
Crossref
Izabela Korona-Glowniak, Ewelina Grywalska, Beata Chudzik, Agnieszka Bojarska-Junak, Anna Malm & Jacek Rolinski. (2012) Upper Respiratory Tract Colonization by Gram-Negative Rods in Patients with Chronic Lymphocytic Leukemia: Analysis of Risk Factors. The Scientific World Journal 2012, pages 1-7.
Crossref
G. S. GuptaAnita Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications 933 953 .
Vicki A. Morrison. (2010) Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Practice & Research Clinical Haematology 23:1, pages 145-153.
Crossref
S H Chaudhry, S Chaudhry, A M Jansen-Hoogendijk, C M Jol van der Zijde, M J D van Tol, A Roos & R G M Bredius. (2009) Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT. Bone Marrow Transplantation 45:2, pages 289-293.
Crossref
Elias Anaissie. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 261 292 .
Vicki A. Morrison. (2007) Management of Infectious Complications in Patients with Chronic Lymphocytic Leukemia. Hematology 2007:1, pages 332-338.
Crossref
James C. Barton & Raoult C. Ratard. (2006) Vibrio vulnificus Bacteremia Associated with Chronic Lymphocytic Leukemia, Hypogammaglobulinemia, and Hepatic Cirrhosis: Relation to Host and Exposure Factors in 252 V. Vulnificus Infections Reported in Louisiana. The American Journal of the Medical Sciences 332:4, pages 216-220.
Crossref
Farhad Ravandi & Susan O’Brien. (2005) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunology, Immunotherapy 55:2, pages 197-209.
Crossref
S. Thiel, P.D. Frederiksen & J.C. Jensenius. (2006) Clinical manifestations of mannan-binding lectin deficiency. Molecular Immunology 43:1-2, pages 86-96.
Crossref
Farhad Ravandi & Susan O’Brien. (2005) Infections associated with purine analogs and monoclonal antibodies. Blood Reviews 19:5, pages 253-273.
Crossref
Edward N. Janoff & Jeffrey B. Rubins. 2004. The Pneumococcus. The Pneumococcus 252 280 .
William G. Wierda. (2003) Immunologic monitoring in chronic lymphocytic leukemia. Current Oncology Reports 5:5, pages 419-425.
Crossref
Susan N. O’Brien, Nicole M.A. Blijlevens, Tahsine H. Mahfouz & Elias J. Anaissie. (2003) Infections in Patients with Hematological Cancer: Recent Developments. Hematology 2003:1, pages 438-472.
Crossref
Marjatta Sinisalo, Janne Aittoniemi, Petri Oivanen, Helena Käyhty, Rose‐Marie Ölander & Juhani Vilpo. (2002) Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. British Journal of Haematology 114:1, pages 107-110.
Crossref
Thomas J. Kipps. (2000) Chronic lymphocytic leukemia. Current Opinion in Hematology 7:4, pages 223-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.